158 completed. 158 Phase 2, 24 Phase 1, 21 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 158 | Completed 158 |
| Phase 1 | 24 | Completed 24 |
| Phase 3 | 21 | Completed 21 |
Follow Smoking: new trials by email Literature Review of Smoking trials Research Report on Smoking
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CAN-DOSE Study: Cessation With Augmented Nicotine for Dual Use Of Smoking and E-cigarettes Regular Nicotine patch and lozenge dose, Augmented Nicotine patch and lozenge dose - Smoking Cessation, Electronic Cigarette Use | Phase 2 | Completed | Medical University of South Carolina | 46 | 2023-12-05 | 2025-11-26 |
| Free Samples for Health Ask-Advise-Refer, Nicotine Patch, 14 Mg/24 Hr Transdermal Film, Extended Release, Nicotine lozenge - Cigarette Smoking | Phase 2 | Completed | Sandra Japuntich | 1239 | 2023-06-12 | 2026-07-24 |
| Exenatide for Smoking Cessation and Prevention of Weight Gain Exenatide 2 milligram (mg) Injection, Placebo, Nicotine patch - Smoking Cessation, Weight Gain | Phase 2 | Completed | The University of Texas Health Science Center, Houston | 140 | 2022-12-07 | 2026-03-23 |
| Transcranial Magnetic Stimulation in Smokers: an Examination of Mediating Neural Pathways. Active repetitive Transcranial Magnetic Stimulation, Sham repetitive Transcranial Magnetic Stimulation - Smoking | Phase 2 | Completed | Kent State University | 6 | 2022-11-08 | 2024-03-08 |
| Varenicline for Treatment of E-cigarette Dependence Varenicline Tartrate, Placebo - Smoking Cessation | Phase 2 | Completed | Yale University | 40 | 2022-11-04 | 2024-12-02 |
| Impact of Flavors on Nicotine Perception and Self-Administration Via E-cigarettes Nicotine 0 mg/mL, Nicotine 6 mg/mL, Nicotine 12 mg/mL - Nicotine, E-liquid Flavors | Phase 2 | Completed | Yale University | 54 | 2022-10-27 | 2024-08-05 |
| Semaglutide for Alcohol Use Disorder Semaglutide, Sham/placebo - Alcohol Use Disorder, Cigarette Smoking | Phase 2 | Completed | University of North Carolina, Chapel Hill | 48 | 2022-09-02 | 2025-04-02 |
| A Study of Cytisinicline for Vaping Cessation in Adult Smokers cytisinicline, Placebo, Behavioral support - Vaping, E-Cig Use | Phase 2 | Completed | Achieve Life Sciences | 160 | 2022-07-13 | 2026-01-14 |
| Pulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke Cigarettes E-Cigarette, Financial Incentives - Chronic Obstructive Pulmonary Disease, Chronic Bronchitis | Phase 2 | Completed | University of Vermont | 21 | 2022-04-28 | 2024-02-08 |
| Mobile Health Technology for Personalized Tobacco Cessation Support Among Cancer Survivors in Laos Nicotine patch, Self-help materials (to support smoking cessation), Smartphone-based automated treatment for smoking cessation - Cigarette Smoking | Phase 2 | Completed | University of Oklahoma | 80 | 2022-04-20 | 2024-08-28 |
| Incentives for Oklahoma Tobacco Helpline Engagement in Persistent Poverty Counties Coaching calls, Nicotine replacement therapy, Financial Incentives - Cigarette Smoking, Nicotine Dependence | Phase 2 | Completed | University of Oklahoma | 165 | 2022-03-09 | 2024-12-30 |
| Heart Rate Variability Biofeedback for Smoking Cessation Treatment Cognitive-Behavioral Smoking Cessation, Heart Rate Variability Biofeedback, Nicotine patch - Tobacco Smoking | Phase 2 | Completed | Rutgers, The State University of New Jersey | 28 | 2021-11-29 | 2024-05-01 |
| Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts Nicoderm CQ 21Mg/24Hr Transdermal System - Tobacco Use Cessation | Phase 2 / Phase 3 | Completed | Brown University | 49 | 2021-09-01 | 2025-04-06 |
| Proactive Outreach for Smoking Treatment Study 3: Chronic care management, Study 2: Pilot trial - Smoking, Tobacco, Mental Illness | Phase 2 | Completed | Sandra Japuntich | 94 | 2021-07-14 | 2025-12-08 |
| Quit Smoking Study for People Who Use E-Cigarettes Nicotine replacement therapy patch, Nicotine replacement therapy lozenge, Quit electronic cigarettes - Nicotine Addiction, E-Cig Use | Phase 2 | Completed | University of Vermont | 396 | 2021-06-27 | 2025-05-22 |
| The Role of Nicotine and Non-Nicotine Alkaloids in E-Cigarette Use and Dependence E-cigarettes - Nicotine Dependence | Phase 1 / Phase 2 | Completed | Duke University | 20 | 2021-05-21 | 2024-02-21 |
| STARS (Smoking Treatment And Remote Sampling) Study Varenicline 0.5 MG, Nicotine Replacement Therapy (NRT) - Smoking, Smoking Cessation | Phase 1 / Phase 2 | Completed | Medical University of South Carolina | 652 | 2021-02-08 | 2026-02-17 |
| E-cigarette Nicotine Study Nicotine, Juul e-cigarette, Reduction - Nicotine Dependence, Electronic Cigarette Use | Phase 2 | Completed | University of Vermont | 77 | 2021-01-20 | 2022-08-26 |
| Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder E cigarettes, Nicotine Replacement Therapy - Cigarette Smoking, Addiction | Phase 2 | Completed | NYU Langone Health | 48 | 2020-10-27 | 2024-12-20 |
| Low Nicotine Content Cigarettes in Vulnerable Populations: Affective Disorders Either normal nicotine content cigarettes (15.8mg/g) or reduced nicotine content cigarettes (0.4mg/g), E-Cigarettes - Tobacco Use Disorder | Phase 2 | Completed | Brown University | 326 | 2020-10-18 | 2025-04-01 |
Showing 20 of 158. Sign in to see all of them.
Smoking Cessation (52) · Tobacco Use Disorder (50) · Cigarette Smoking (45) · Vaping (12) · Alcoholism (8) · Marijuana Smoking (7) · Schizophrenia (7) · Tobacco Smoking (6) · Tobacco Use Cessation (6) · Alcohol Drinking (5) · Asthma (4) · Behavior, Addictive (4) · Body Weight (4) · Pulmonary Disease, Chronic Obstructive (4)
Behavior (158) · Mental Disorders (75) · Chemically-Induced Disorders (61) · Substance-Related Disorders (60) · Health Behavior (58) · Tobacco Use (48) · Tobacco Smoking (43) · Pathological Conditions, Signs and Symptoms (14) · Lung Diseases (10) · Respiratory Tract Diseases (10) · Smoking, Non-Tobacco Products (8) · Alcohol-Related Disorders (7) · Pathologic Processes (7) · Schizophrenia Spectrum and Other Psychotic Disorders (7)
Varenicline (24) · Tobacco Use Cessation Devices (22) · Nicotine (17) · Nicotine Replacement Therapy (12) · Bupropion (11) · Electronic Nicotine Delivery Systems (7) · Naltrexone (7) · Nicotine Chewing Gum (5) · Behavior Therapy (4) · Cognitive Behavioral Therapy (4) · Counseling (4) · Sugars (4) · Dronabinol (3) · Ethanol (3) · Mecamylamine (3)
Yale University (20) · Mayo Clinic (9) · Brown University (7) · Duke University (6) · Medical University of South Carolina (5) · National Institute on Drug Abuse (NIDA) (5) · University of Pennsylvania (4) · University of Vermont (4) · National Cancer Institute (NCI) (3) · The University of Texas Health Science Center, Houston (3) · University of Minnesota (3) · Centre for Addiction and Mental Health (2) · GlaxoSmithKline (2) · Johns Hopkins University (2) · Maastricht University Medical Center (2)
United States (131) · Canada (3) · Brazil (2) · Denmark (2) · France (2) · Israel (2) · Netherlands (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Czechia (1) · Egypt (1) · Finland (1) · Hungary (1) · India (1)
Sherry A McKee, PhD (4) · Jed E Rose, Ph.D. (3) · Jed E. Rose, Ph.D. (2) · Laura MacPherson, PhD (2) · Luba Yammine, PhD (2) · Stephanie O'Malley, PhD (2) · Suchitra Krishnan-Sarin, Ph.D. (2) · Allan V. Prochazka, MD MSc (1) · Allen Zweben, PhD (1) · Amanda Palmer (1) · Amit Sood, M.D., MSc (1) · Amit Sood, MD (1) · Andrea C King, PhD (1) · Andrew Strasser, MBBS, PhD (1)
PMID 37142273, PMID 37230961, PMID 29663982, PMID 34611902, PMID 39240566, PMID 42560883, PMID 15534159, PMID 16240558, PMID 17587504, PMID 18480694, PMID 18686184, PMID 19196814, PMID 19483180, PMID 19524389, PMID 20056957, PMID 20078491, PMID 20081039, PMID 20191360, PMID 20334673, PMID 20434863, PMID 20466951, PMID 20542391, PMID 20590478, PMID 20719253, PMID 20947286, PMID 21163939, PMID 21221531, PMID 21270788, PMID 21276244, PMID 21356232, PMID 21473764, PMID 21652735, PMID 21928117, PMID 22007015, PMID 22097928, PMID 22157229, PMID 22229310, PMID 22352784, PMID 22592966, PMID 22741619, PMID 22761006, PMID 22898118, PMID 22993168, PMID 23177384, PMID 23216646, PMID 23265707, PMID 23282113, PMID 23536105, PMID 24399554, PMID 24894625
P50AA015632 (5), P50DA027840 (4), P50DA033945 (3), U54DA036114 (3), P50DA013333 (2), R34DA043751 (2), 2004 (1), 2014 (1), K01DA019446 (1), K01MD015295 (1), K23DA022471 (1), K23DA039294 (1), N01CN35159 (1), P01AA027473 (1), P30CA068485 (1)